Galectin Therapeutics (GALT) Reports Q2 Loss of $0.14/Share

Go back to Galectin Therapeutics (GALT) Reports Q2 Loss of $0.14/Share
GALECTIN (NASDAQ: GALT) Delayed: 3.12 +0.32 (11.43%)
Previous Close $2.80    52 Week High $3.05 
Open $2.71    52 Week Low $0.49 
Day High $3.70    P/E N/A 
Day Low $2.71    EPS $-1.32 
Volume 3,901,471